MedTrace Logo

Omega-3 Fatty Acids on Fasting and Postprandial Triglycerides (TG) Response - a Pilot Study

NCT05621083 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 34

Last updated 2025-03-28

No results posted yet for this study

Summary

The aim of this project is to elucidate how repeated exposure with omega-3 fatty acid supplementation for 6 weeks affect mean and individual fasting lipids and inflammatory responses and postprandial TG after a high fat meal with butter (50 g fat) in healthy subjects.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

Omega- 3

In the fish oil supplement period, the participants will receive concentrated fish oil which is equal to in total 2.3 g EPA+DHA per day during 6 weeks.

DIETARY_SUPPLEMENT

HOSO

In the HOSO period, the participants will receive similar amount of HOSO per day during 6 weeks.

Sponsors & Collaborators

  • Throne-Holst Foundation for Nutrition Research

    collaborator UNKNOWN

  • Horizon 2020 - European Commission

    collaborator OTHER

  • GC Rieber VivoMega AS

    collaborator UNKNOWN

  • University of Oslo

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-11
Primary Completion
2025-01-31
Completion
2025-01-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05621083 on ClinicalTrials.gov